Distributional effects of 'general population' prescription drug programs in Canada

被引:12
|
作者
Alan, S [1 ]
Crossley, TF
Grootendorst, P
Veall, MR
机构
[1] York Univ, Dept Econ, N York, ON M3J 1P3, Canada
[2] McMaster Univ, Dept Econ, Hamilton, ON L8S 4L8, Canada
[3] Univ Toronto, Fac Pharm, Toronto, ON, Canada
关键词
D O I
10.1111/j.0008-4085.2005.00272.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Canadian household prescription drug expenditures are studied using the Statistics Canada Family Expenditure Survey masterfiles for periods that include the introduction of provincial 'general population' prescription drug programs. Budget shares for non-senior households are examined over time using non-parametric regression, parametric 'difference-in-difference' techniques, and quantile regression methods. The evidence suggests that while program effects are muted when there are high deductibles, a non-senior prescription drug subsidy is more redistributive than an equal-cost proportional income transfer, in part because of differential private health insurance coverage by income. This is in contrast to previous evidence on Canadian senior prescription drug subsidies.
引用
收藏
页码:128 / 148
页数:21
相关论文
共 50 条
  • [41] The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada
    Alan, S
    Crossley, TF
    Grootendorst, P
    Veall, MR
    JOURNAL OF HEALTH ECONOMICS, 2002, 21 (05) : 805 - 826
  • [42] Research to support optimization of prescription drug monitoring programs
    Doyle, Sheri
    Leichtling, Gillian
    Hildebran, Christi
    Reilly, Cynthia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (11) : 1425 - 1427
  • [43] Interprofessional education workshop for prescription drug monitoring programs
    Howard, Mitchell S.
    Bodi, Shirley M.
    Peeters, Michael J.
    MEDICAL EDUCATION, 2023, 57 (11) : 1161 - 1162
  • [44] Prescription drug monitoring programs in the United States of America
    Felix, Sausan El Burai
    Mack, Karin
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (04): : 270 - 276
  • [45] Community Pharmacist Involvement in Prescription Drug Monitoring Programs
    Doong, Katie S.
    Gaccione, Daniella M.
    Brown, Todd A.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (06) : 227 - 229
  • [46] EFFECT OF PRESCRIPTION DRUG MONITORING PROGRAMS ON TESTOSTERONE PRESCRIPTIONS
    Mulloy, E.
    Eisenberg, M.
    Li, S.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04): : S122 - S122
  • [47] Prescription Drug Monitoring Programs and Opioid Death Rates
    Rudman, William, Jr.
    Corcoran, Peter
    Elliot, Kimberly
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (20): : 2044 - 2044
  • [48] Perceived Unintended Consequences of Prescription Drug Monitoring Programs
    Lai, Alden Yuanhong
    Smith, Katherine C.
    Vernick, Jon S.
    Davis, Corey S.
    Alexander, G. Caleb
    Rutkow, Lainie
    SUBSTANCE USE & MISUSE, 2019, 54 (02) : 345 - 349
  • [49] Recommendations for Lowering Prescription Drug Spending in Public Programs
    Jazowski, Shelley A.
    Dusetzina, Stacie B.
    ANNALS OF INTERNAL MEDICINE, 2019, 171 (11) : 855 - +
  • [50] Prescription drug monitoring programs, opioid abuse, and crime
    Dave, Dhaval
    Deza, Monica
    Horn, Brady
    SOUTHERN ECONOMIC JOURNAL, 2021, 87 (03) : 808 - 848